Patents for A61P 17 - Drugs for dermatological disorders (106,455)
04/2008
04/09/2008EP1908476A1 Galectin-2 for the treatment of inflammatory diseases of the skin
04/09/2008EP1908453A1 Alkyl ether citrates for selective cleansing of skin
04/09/2008EP1906992A1 Use of a mixture of superoxide dismutase and catalase for treating inflammatory skin lesions
04/09/2008EP1906978A1 Composition for treating skin lesions
04/09/2008EP1536764B1 Cosmetic composition for fighting against skin ageing
04/09/2008EP1450853A4 Lipoprotein lipase and lipoprotein lipase activators in the treatment of inflammatory conditions
04/09/2008EP1439837B1 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors
04/09/2008EP1325060B1 Soybean-based thermoplastics as biomaterials
04/09/2008EP1309565B1 Heterocyclic mutilin esters and their use as antibacterials
04/09/2008EP1173767B1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes
04/09/2008EP1140964B1 Connective tissue growth factor (ctgf) fragment
04/09/2008EP0972028B1 Mutants of vascular endothelial growth factor c (vegf-c) and uses thereof
04/09/2008EP0964864B1 Pyrido 2,3-d pyrimidines and 4-aminopyrimidines as inhibitors of cellular proliferation
04/09/2008CN101160322A Molecules and chimeric molecules thereof
04/09/2008CN101160290A 7-membered ring compound, process for producing the same, and medicinal use thereof
04/09/2008CN101156939A A medicine for treating tinea manuum
04/09/2008CN101156934A Spray for treating burn
04/09/2008CN101156925A A traditional Chinese medicine preparation for treating children dermatosis
04/09/2008CN101156899A New medicament usage of paeonol unction
04/09/2008CN101156890A A externally use nebula pressurized spray for treating ulcer and solar dermatitis of dermatosis
04/09/2008CN101156867A Tea polyphenol pellicle and method for making same
04/09/2008CN101156680A Food composition of nourishing blood anti-senescence and method for producing same
04/09/2008CN100379881C Skin treatment
04/09/2008CN100379855C Monkey monoclonal antibodies specific to human b. 7.1 and/or B7.2 primatized forms, pharmaceutical compositions
04/09/2008CN100379737C Thioxanthine derivatives as myeloperoxidase inhibitors
04/09/2008CN100379735C 1,2,3,4,7,8-hexahydro-6h-[1,4]diazepino[6,7,1-1j]quinoline derivatives as antipsychotic and antiobesity agents
04/09/2008CN100379734C Azaindoles
04/09/2008CN100379727C Substituted pyrazolyl benzenesulfonamides for the treatment of inflamation
04/09/2008CN100379719C Substituted aminomethyl-phenyl-cyclohexane derivatives
04/09/2008CN100379447C Composition containing PVA-124 and its application
04/09/2008CN100379442C Skin care medicated liquid for eliminating acne
04/09/2008CN100379438C Glucoside active site LWD-b in Liuwei Dihuang decoction, its preparation method
04/09/2008CN100379434C Medicine for treating manus and pedes tinea and its preparation method
04/09/2008CN100379423C Topical medicine composite containing cholinergic drug or calcium channel paralyser
04/09/2008CN100379395C Method for covering an open wound, and manufacturing of a wound dressing for covering an open wound
04/08/2008US7355081 androgen receptor antagonists; certain cancers, baldness, hirsutism, behavioral disorders, acne, and inhibition of spermatogenesis if so desired
04/08/2008US7355063 Antioxidants; hyaluronic acid-degrading enzyme inhibitor; water solubility; useful in the fields of foods, medicines, quasi-drugs, cosmetics; analogous to shogaol and gingerol
04/08/2008US7355015 Matriptase, a serine protease and its applications
04/08/2008US7354947 Isothiazoloanthrones, isoxazoloanthrones, isoindolanthrones and derivatives thereof a JNK inhibitors and compositions and methods related thereto
04/08/2008US7354941 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of PDE4 isozymes
04/08/2008US7354940 2,5-dioxoimidazolidin-4-yl acetamines and analogues as inhibitors of metalloproteinase mmp12
04/08/2008US7354934 N1-(1H-Benzimidazol-2-ylmethyl)-N1-(5,6,7,8-tetrahydro-quinolin-8-yl)-butane-1,4-diamine; fusin and chemokine receptor antagonist; increase progenitor and stem cells in humans; HIV, antiinflammatory agent: rheumatoid arthritis, inflammatory bowel disease
04/08/2008US7354931 Treating obstructive airway disorders using nontoxic drug
04/08/2008US7354926 Molecules derived from noraporphine
04/08/2008US7354919 Isoxazole compositions useful as inhibitors of ERK
04/08/2008US7354736 Intracellular caspase inhibitory polypeptide for use in treatment and prevention of cell proliferative, nervous system and autoimmune disorders
04/08/2008US7354610 Phospholipid complexes of standardized vegetable extract of Vitis vinifera and of standardized vegetable extract of Centella asiatica; may also include vitamin E, zinc, hydroxyacids, or glycyrrhetinic acid or its complex with phospholipids; does not contain fish cartilage extract
04/08/2008CA2372962C Novel interleukin-1 and tumor necrosis factor-.alpha. modulators, syntheses of said modulators and methods of using said modulators
04/08/2008CA2337886C Pharmaceutical compositions comprising hydroxylansoprazole and uses thereof
04/03/2008WO2008039754A1 2-methylene-(20r,25s)-19,27-dinor-(22e)-vitamin d analogs
04/03/2008WO2008038807A1 External composition for skin
04/03/2008WO2008038806A1 Antipruritic agent
04/03/2008WO2008038771A1 Glutamine-containing composition for increasing blood flow
04/03/2008WO2008038711A1 Oxepin derivative
04/03/2008WO2008038692A1 Diaryl ketimine derivative
04/03/2008WO2008037937A2 Use of compounds of the milbemycin family for the treatment of dermatological disorders in human beings
04/03/2008WO2008037936A1 Use of compounds of the milbemycin family for the treatment of dermatological disorders in human beings
04/03/2008WO2008037935A2 Use of 6'-ethyl-lepimectine, 6'-methyl-lepimectine or derivatives thereof for the treatment of dermatological disorders in human beings
04/03/2008WO2008037934A1 Use of compounds of the avermectin family for the treatment of dermatological disorders in human beings
04/03/2008WO2008037933A1 Use of compounds of the avermectin family for the treatment of dermatological disorders in human beings
04/03/2008WO2008037931A1 Use of compounds of the avermectin family for the treatment of dermatological disorders
04/03/2008WO2008037497A2 Galectin-2 for the treatment of inflammatory diseases of the skin
04/03/2008WO2008037262A1 Wound healing composition comprising phosphate, iron and copper
04/03/2008WO2008014291A3 Compounds and compositions as hedgehog signaling pathway modulators
04/03/2008WO2007119028A3 Composition including at least one aqueous phase and at least one fatty phase including ivermectin
04/03/2008US20080081838 Inhibition of TNF-alpha-Initiated Neutrophil Response
04/03/2008US20080081822 N-(5-tert-Butyl-isoxazol-3-yl)-2-cyclohexanesulfonyl-2-methyl-propionamide; cannabinoid receptor agonist, antagonist; analgesic, antiinflammatory and antitumor agent; neuropatic pain
04/03/2008US20080081800 2-Methylene-(20R,25S)-19,27-Dinor-(22E)-Vitamin D Analogs
04/03/2008US20080081799 2-Methylene-(20S,25S)-19,27-Dinor-(22E)-Vitamin D Analogs
04/03/2008US20080081082 Topical Skin Compositions, Their Preparation, and Their Use
04/03/2008US20080081036 Using topical mixture to repair and condition animal skin
04/03/2008US20080081034 Topical Skin Compositions, Their Preparation, and Their Use
04/03/2008DE102007028506A1 Cosmetic or dermatological deodorant or antitranspirant composition, useful as skin care formulation, comprises deodorant or antitranspirant active agent and dihydroquercetin in a carrier
04/03/2008DE102007022449A1 Cosmetic or dermatological skin treating agent, useful to treat acne and/or unclean skin, comprises a carrier and a photocatalytically effective metal oxide e.g. titanium dioxide, as an active agent
04/03/2008DE102006047157A1 Cosmetic or dermatological composition comprises 2-isopropyl-5-methylcyclohexylcarbonyl-D-alanine methyl ester and a skin lightener
04/03/2008DE102006047156A1 Cosmetic or dermatological composition comprises 2-isopropyl-5-methylcyclohexylcarbonyl-D-alanine ethyl ester and a skin lightener
04/03/2008CA2664358A1 Diarylketimine derivative
04/03/2008CA2664345A1 Oxepin derivative
04/03/2008CA2662992A1 2-methylene-(20r,25s)-19,27-dinor-(22e)-vitamin d analogs
04/03/2008CA2662864A1 2-methylene-(20s,25s)-19,27-dinor-(22e)-vitamin d analogs
04/02/2008EP1905830A1 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
04/02/2008EP1905782A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
04/02/2008EP1905779A1 Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method of obtaining same
04/02/2008EP1905771A2 Quinuclidine derivatives and their use
04/02/2008EP1905457A1 Angiogenesis and vascular permeability modulators and inhibitors
04/02/2008EP1905441A2 Non-sedating barbiturate compounds as neuroprotective agents
04/02/2008EP1904500A1 New derivatives of heptaazaphenalene, methods for obtaining them, and their use as protecting agents against uv radiation
04/02/2008EP1904478A1 Acid addition salts of n-ethyl-n'-[2-methoxy-4-(5-methyl-4-{[(1s)-1-pyridin-3-ylbutyl]amino}pyrimidin- 2-yl)phenyl]urea and uses thereof
04/02/2008EP1904432A2 Oligomers of straight-chain and unbranched fatty acids, and medicaments containing the same
04/02/2008EP1904094A2 Use of vegf for wound healing
04/02/2008EP1482959B1 Compositions for treatment of skin disorders
04/02/2008EP1476019B1 Aqueous antiseptic based on bispyridiniumalkanes
04/02/2008EP1397153B1 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules
04/02/2008EP1232147B1 Triazoles as farnesyl transferase inhibitors
04/02/2008CN101155814A Crystals of morphinan derivative and process for producing the same
04/02/2008CN101155790A 1,2,4-triazine derivatives, preparation and use thereof in human therapy
04/02/2008CN101155594A Cream loaded with shellfish firing product powder and process for producing the same
04/02/2008CN101155589A Composition for reducing the exudation of serum proteins
04/02/2008CN101155576A Anti-wrinkle agent
04/02/2008CN101153042A Thienopyrimidine compound and use of the same